environment and health featured Global Health government and politics Health Care Reform Health Economics Healthcare Equity International health Personal health politics and health Pre-Exposure Prophylaxis Public health Policy Sexual Health Uncategorized

Generic Truvada; why is it still not available on the US market?

In the US most patients who require PrEP (HIV Pre-Exposure Prophylaxis) get coverage for Truvada by their insurance companies. Patients with medicaid coverage have copays ranging from $3 – 25, however individuals with commercial insurance may have to pay up to $800 a month towards medication cost. This has proven to be a barrier for […]

Advertisements